Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0C2KF
|
|||
Former ID |
DIB010995
|
|||
Drug Name |
JNJ-26489112
|
|||
Synonyms |
Anticonvulsant agent (epilepsy), J&J PRD
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Epilepsy [ICD-11: 8A60-8A68] | Phase 2 | [1] | |
Company |
Johnson & Johnson Pharmaceutical Research & Development LLC
|
|||
Structure |
Download2D MOL |
|||
Formula |
C9H11ClN2O4S
|
|||
Canonical SMILES |
C1C(OC2=C(O1)C=C(C=C2)Cl)CNS(=O)(=O)N
|
|||
InChI |
1S/C9H11ClN2O4S/c10-6-1-2-8-9(3-6)15-5-7(16-8)4-12-17(11,13)14/h1-3,7,12H,4-5H2,(H2,11,13,14)/t7-/m0/s1
|
|||
InChIKey |
KXSAIQPPGSSNKX-ZETCQYMHSA-N
|
|||
CAS Number |
CAS 871824-55-4
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00579384) A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive Epilepsy. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.